期刊文献+

左旋氨氯地平与缬沙坦联用对2型糖尿病肾病疗效 被引量:1

暂未订购
导出
摘要 目的:观察左旋氨氯地平和缬沙坦联用对早期糖尿病肾病的保护作用。方法:2型糖尿病肾病患者158例,随机分为苯磺酸左旋氨氯地平与缬沙坦联合应用组(A组)和缬沙坦组(B组),观察治疗6个月前后两组患者的血压、白蛋白尿排泄率、血清肌酐和尿素氮的变化。结果:两组均可明显降低血压,减少24 h白蛋白尿排泄量,降低血压幅度组间对比差异无统计学意义(P>0.05),但A组降低24 h白蛋白尿排泄量更明显(P<0.05)。
出处 《天津药学》 2012年第6期32-33,共2页 Tianjin Pharmacy
  • 相关文献

参考文献2

二级参考文献21

  • 1Ruilope LM. The kidney as a sensor of cardiovascular risk in essential hypertension[ J ]. J Am Soc Nephrol, 2002,13 : 165-168.
  • 2Segura J, Ruilope LM,Rodicio JL. Microalbuminuria[J]. Clin Exp Hypertens, 2004,26 : 701-707.
  • 3Stam F, Guldener C, Schalkwijk CG,et al. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity [J ]. Nephrol Dial Transplant,2003,18: 892-898.
  • 4Pedrinelli R,Dell'Omo G, Penno G, et al. Microalbuminuria, a parameter independent of metabolic influences in hypertensive men[J].J Hypertens, 2003,21 : 1163-1169.
  • 5Lassila M, Cooper ME, Jandeleit-Dahm K. Antiproteinuric effect of RAS blockade: new mechanisms [J]. Curr Hypertens Rep, 2004,6 : 383 -392.
  • 6Cowley AW Jr. Role of the renal medulla in volume and arterial pressure regulation[J]. Am J Physiol, 1997,273:1-15.
  • 7Skov K, Mulvany MJ. Structure of renal afferent arterioles in the pathogenesis of hypertension[J]. Acta Physiol Stand, 2004,181:397-405.
  • 8Hlubocka Z, Umnerova V, Heller S, et al. Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy[J]. Vnitr Lek,2002,48 : 718-723.
  • 9Le Bricon T. Laboratory identification and measurement of urinary proteins[J]. Ann Biol Clin, 2002,60 : 525-540.
  • 10Culleton BF, Larson MG, Wilson PW, et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency[J]. Kidney Int, 1999,56 : 2214-2219.

共引文献13

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部